Risk factors for positive resection margins after endoscopic resection for gastrointestinal neuroendocrine tumors

Surg Endosc. 2024 Apr;38(4):2041-2049. doi: 10.1007/s00464-024-10706-0. Epub 2024 Mar 1.

Abstract

Background: In recent years, the incidence of gastrointestinal neuroendocrine tumors (GI-NETs) has remarkably increased due to the widespread use of screening gastrointestinal endoscopy. Currently, the most common treatments are surgery and endoscopic resection. Compared to surgery, endoscopic resection possesses a higher risk of resection margin residues for the treatment of GI-NETs.

Methods: A total of 315 patients who underwent surgery or endoscopic resection for GI-NETs were included. We analyzed their resection modality (surgery, ESD, EMR), margin status, Preoperative marking and Prognosis.

Results: Among 315 patients included, 175 cases underwent endoscopic resection and 140 cases underwent surgical treatment. A total of 43 (43/175, 24.57%) and 10 (10/140, 7.14%) patients exhibited positive resection margins after endoscopic resection and surgery, respectively. Multivariate regression analysis suggested that no preoperative marking and endoscopic treatment methods were risk factors for resection margin residues. Among the patients with positive margin residues after endoscopic resection, 5 patients underwent the radical surgical resection and 1 patient underwent additional ESD resection. The remaining 37 patients had no recurrence during a median follow-up of 36 months.

Conclusions: Compared with surgery, endoscopic therapy has a higher margin residual rate. During endoscopic resection, preoperative marking may reduce the rate of lateral margin residues, and endoscopic submucosal dissection may be preferred than endoscopic mucosal resection. Periodical follow-up may be an alternative method for patients with positive margin residues after endoscopic resection.

Keywords: EMR; ESD; Endoscopy; Gastrointestinal neuroendocrine tumors; Positive resection margins.

MeSH terms

  • Endoscopic Mucosal Resection* / methods
  • Gastrointestinal Neoplasms* / pathology
  • Gastrointestinal Neoplasms* / surgery
  • Humans
  • Intestinal Mucosa / surgery
  • Margins of Excision
  • Neuroendocrine Tumors* / pathology
  • Neuroendocrine Tumors* / surgery
  • Rectal Neoplasms* / surgery
  • Retrospective Studies
  • Risk Factors
  • Treatment Outcome